sensipar — Main — tl;dr pharmacy

Posts tagged sensipar

New FDA Approval: Parsabiv

New FDA Approval: Parsabiv

Drug

Etelcalcitide [Parsabiv]

Indication

The treatment of secondary hyperparathyroidism in adults on dialysis.

Clinical, FDA Approval, Pharmacy School, PracticeBrandon DysonFebruary 13, 2017hyperparathyroidism, PTH, parathyroid gland, etelcalcitide, Parsabiv, secondary hyperparathyroidism, calcimimetic, phosphate binder, osteoclast, bone resorption, calcium metabolism, sensipar, cinacalcet